Suchergebnisse - "Carbone, Salvatore"

PubPharm (9)

1

Interleukin-1 blockade in heart failure : an on-treatment and off-treatment cardiorespiratory fitness analysis

enthalten in: ESC heart failure | 2023

von Moroni, F. | Golino, M. | Carbone, S. | +8

2

Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure

enthalten in: The American journal of cardiology | 2022

von Mihalick, V. | Wohlford, G. | Talasaz, A. | +12

3

Potential role for interleukin-1 in the cardio-renal syndrome

enthalten in: European journal of heart failure | 2019

von Buckley, L. | Canada, J. | Carbone, S. | +7

4

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3) : A randomized, placebo-controlled, double-blinded, multicenter study

enthalten in: Clinical cardiology | 2018

von Van Tassell, B. | Lipinski, M. | Appleton, D. | +22

5

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction

enthalten in: Circulation. Heart failure | 2018

von Van Tassell, B. | Trankle, C. | Canada, J. | +13

6

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work : A Post Hoc Pooled Analysis of 2 Clinical Trials

enthalten in: Journal of cardiovascular pharmacology | 2018

von Buckley, L. | Carbone, S. | Trankle, C. | +9

7

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure : Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)

enthalten in: Circulation. Heart failure | 2017

von Van Tassell, B. | Canada, J. | Carbone, S. | +19

8

Interleukin-1 blockade in heart failure with preserved ejection fraction : rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)

enthalten in: Clinical cardiology | 2017

von Van Tassell, B. | Buckley, L. | Carbone, S. | +8

9

Interleukin-1 Blockade in Acute Decompensated Heart Failure : A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

enthalten in: Journal of cardiovascular pharmacology | 2016

von Van Tassell, B. | Abouzaki, N. | Oddi Erdle, C. | +14

1
[1]